REFERENCES
1. Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 1999;141:398-405.
2. Girman CJ, Rhodes T, Lilly FR, et al. Effects of self-perceived hair loss in a community sample of men. Dermatology 1998;197:223-9.
3. Kim BK, Lee S, Jun M, Chung HC, Oh SS, Lee WS. Perception of hair loss and education increases the treatment willingness in patients with androgenetic alopecica: a population-based study. Ann Dermatol 2018;30:402-8.
4. Guarrera M, Cardo P, Arrigo P, Rebora A. Reliability of hamilton-norwood classification. Int J Trichology 2009;1:120-2.
5. Dawber R, Van Neste D. Hair and Scalp Disorders. Common Presenting Signs, Differential Diagnosis and Treatment. London: Martin Dunitz; 1995. pp. 1-294.
6. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942;71:451-80.
7. Ayob SM, Messenger AG. Androgens, hair loss and eugenics: a tale of discovery and American social history. Exp Dermatol 2015;24:412-3.
8. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-54.
9. Van Neste D. My management plan of the male patient with androgenetic alopecia. In: Van Neste D, Blume-Peytavi U, Grimalt R, Messenger A, editors. Hair Science and Technology. Tournai-Belgium: Skinterface sprl Pub.; 2003. pp. 301-10.
10. Van Neste D. Photographic techniques and quantification of hair growth. In: Humbert P, Fanian F, Maibach HI, Agache P, editors. Agache’s Measuring Skin. Springer Pub; 2017. pp. 767-86.
11. Van Neste D. Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles. Skin Res Technol 2019;25:701-11.
12. Van Neste D. Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a “drug dependency” and a post-finasteride “rebound effect”. Skin Res Technol 2019;25:712-9.
13. Van Neste D. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol. Skin Res Technol 2020;26:542-57.
14. Hugh Rushton D, Norris MJ, Van Neste D. Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair. Exp Dermatol 2016;25:482-4.
15. Van Neste D. Photographic techniques and quantification of hair growth in TRICHOLOGY: Diseases of pilosebaceous follicle. In: Camacho F, Tosti A, Randall V, editors. Grupo PV, Aula Médica SL. Édition: 3. 2017.
16. Van Neste D. Why care about linear hair growth rates (LHGR)? a study using in vivo imaging and computer assisted image analysis after manual processing (CAIAMP) in unaffected male controls and men with male pattern hair loss (MPHL). Eur J Dermatol 2014;24:568-76.
17. Rushton DH, Gilkes JJ, Van Neste DJ. No improvement in male-pattern hair loss using laser hair-comb therapy: a 6-month, half-head, assessor-blinded investigation in two men. Clin Exp Dermatol 2012;37:313-5.
18. Van Neste D, Sandraps E, Herbaut D, Lelubre P, Leroy T. Validation of scalp coverage scoring methods for scalp hair loss in male pattern hair loss (androgenetic alopecia). Skin Res Technol 2006;12:89-93.
19. Kaufman KD, Olsen E, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-89.
20. Van Neste D. Contrast enhanced phototrichogram (CE-PTG): an improved non-invasive technique for measurement of scalp hair dynamics in androgenetic alopecia - validation study with histology after transverse sectioning of scalp biopsies. Eur J Dermatol 2001;4:326-31.
21. Leroy T, Van Neste D. Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia. Skin Res Technol 2002;8:106-11.
22. Van Neste D, Leroy T, Conil S. Exogen hair characterization in human scalp. Skin Res Technol 2007;13:436-43.
23. Van Neste D. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride. Skin Pharmacol Physiol 2006;19:168-76.
24. Reygagne P. Phototrichogram. In: Humbert P, Maibach H, Fanian F, Agache P, editors. Measuring the Skin. Cham: Springer International Publishing; 2016. pp. 1-13.
25. Kasprzak M, Sicińska J, Sinclair R. The Trichoscopy Derived Sinclair Scale: Enhancing visual assessment through quantitative trichoscopy. Australas J Dermatol 2019;60:134-6.
26. Venning V, Dawber R. Patterned androgenic alopecia in women. J Am Acad Dermatol 1988;18:1073-107.
27. Wang Q, Oh JW, Lee HL, et al. A multi-scale model for hair follicles reveals heterogeneous domains driving rapid spatiotemporal hair growth patterning. Elife 2017;6:e22772.
28. Guarrera M, Rebora A. Anagen hairs may fail to replace telogen hairs in early androgenic female alopecia. Dermatology 1996;192:28-31.
30. Hagenaars SP, Hill WD, Harris SE, et al. Genetic prediction of male pattern baldness. PLoS Genet 2017;13:e1006594.
31. Saraogi PP, Dhurat RS. Automated Digital Image Analysis (TrichoScan®) for Human Hair Growth Analysis: Ease versus Errors. Int J Trichology 2010;2:5-13.
32. Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men-short version. J Eur Acad Dermatol Venereol 2018;32:11-22.
33. Leavitt M, Perez-Meza D, Rao NA, Barusco M, Kaufman KD, Ziering C. Effects of finasteride (1 mg) on hair transplant. Dermatol Surg 2005;31:1268-76. discussion 1276
34. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc 1999;4:282-4.
35. Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001;45:S81-6.
36. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. JAAD 2004;51:189-99.
37. Messenger AG, Sinclair R. Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol 2006;155:926-30.
